GPU-Accelerated Drug Discovery with Docking on the Summit Supercomputer: Porting, Optimization, and Application to COVID-19 Research

Scott Legrand, Aaron Scheinberg, Andreas F. Tillack, Mathialakan Thavappiragasam, Josh V. Vermaas, Rupesh Agarwal, Jeff Larkin, Duncan Poole, Diogo Santos-Martins, Leonardo Solis-Vasquez, Andreas Koch, Stefano Forli, Oscar Hernandez, Jeremy C. Smith, Ada Sedova

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

51 Scopus citations

Abstract

Protein-ligand docking is an in silico tool used to screen potential drug compounds for their ability to bind to a given protein receptor within a drug-discovery campaign. Experimental drug screening is expensive and time consuming, and it is desirable to carry out large scale docking calculations in a high-Throughput manner to narrow the experimental search space. Few of the existing computational docking tools were designed with high performance computing in mind. Therefore, optimizations to maximize use of high-performance computational resources available at leadership-class computing facilities enables these facilities to be leveraged for drug discovery. Here we present the porting, optimization, and validation of the AutoDock-GPU program for the Summit supercomputer, and its application to initial compound screening efforts to target proteins of the SARS-CoV-2 virus responsible for the current COVID-19 pandemic.

Original languageEnglish
Title of host publicationProceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
PublisherAssociation for Computing Machinery, Inc
ISBN (Electronic)9781450379649
DOIs
StatePublished - Sep 21 2020
Event11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020 - Virtual, Online, United States
Duration: Sep 21 2020Sep 24 2020

Publication series

NameProceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020

Conference

Conference11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020
Country/TerritoryUnited States
CityVirtual, Online
Period09/21/2009/24/20

Funding

This research was sponsored by the Laboratory Directed Research and Development Program at Oak Ridge National Laboratory (ORNL), which is managed by UT-Battelle, LLC, for the U.S. Department of Energy (DOE) under Contract No. DE-AC05-00OR22725, and used resources of the Oak Ridge Leadership Computing Facility, which is a DOE Office of Science User Facility supported under Contract DE-AC05-00OR22725. Development of the AutoDock-GPU was supported by the National Institutes of Health (GM069832). We thank Jonathan Lefman and Geetika Gupta (NVIDIA) for essential coordination and communication support.

FundersFunder number
Office of Science
U.S. Department of Energy
National Institutes of HealthGM069832
Oak Ridge National Laboratory
U.S. Department of EnergyDE-AC05-00OR22725

    Keywords

    • Drug discovery
    • GPU acceleration
    • high-performance computing
    • protein-ligand docking

    Fingerprint

    Dive into the research topics of 'GPU-Accelerated Drug Discovery with Docking on the Summit Supercomputer: Porting, Optimization, and Application to COVID-19 Research'. Together they form a unique fingerprint.

    Cite this